Souzan Mohamed Amin
Cairo, Cairo Governorate, 11562, Egypt
NCT Number: NCT03416660
This study aims to compare effectiveness of different densities of carbon dioxide fractional laser in the treatment of postburn scar.
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Not applicable
Cairo, Cairo Governorate, 11562, Egypt
The study included 25 Egyptian patients with burn scars recruited from the Out Patient Clinic, Dermatology Department, Cairo University. Each has three post burn scars, assigned to monthly fractional Carbon dioxide laser sessions with a total of 3 sessions. parameters are :
Lesion A or part A parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 900µm spacing (7.4% density).
Lesion B or part B parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 600µm spacing (12.6% density).
Lesion C or part C parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 300 µm spacing (25.6% density).
3 mm punch biopsy is taken before and one month after last session for assessment of collagen via (Masson's trichrome strain). In addition clinical evaluation is done via Vancouver & Patient and Observer Scar Assessment Scale .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month after last session
to compare the efficacy of different densities of fractional laser in treatment of post burn scars
Cairo University
Other
Comparison Between Effectiveness of Different Densities of Fractional Carbon Dioxide Laser in Treatment of Postburn Scar.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07441538
Cicatrix, Cyst
Wuhan, Hubei, China
View Trial DetailsNCT02234193
Cicatrix, Fibrosis
Boston, Massachusetts, United States
View Trial DetailsNCT07384299
Cicatrix, Cyst
Wuhan, Hubei, China
View Trial Details